Introduction

Pharmaceutical manufacturers have achieved significant benefits using automated systems over the years. Reference 1 is a collection of papers from conferences and symposia defining automation projects in the early 1980s. These systems are typically automating a single-unit operation, such as a solid dosage unit operation, laboratory testing, and robotics. In the ensuing years pharmaceutical products have become more complex and clinical trials more lengthy, with greater population samples and regulatory compliance more extensive and important.